THE LIGAND-BINDING SIGNATURES OF THE RAT AT(1A), AT(1B) AND THE HUMAN AT(1) RECEPTORS ARE ESSENTIALLY IDENTICAL

被引:58
作者
CHIU, AT
DUNSCOMB, J
KOSIEROWSKI, J
BURTON, CRA
SANTOMENNA, LD
CORJAY, MH
BENFIELD, P
机构
关键词
D O I
10.1006/bbrc.1993.2499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to determine whether the three isoforms of recombinant Ang II receptors (rAT1A, rAT1B and hAT1), stably and individually expressed in CHO cells, could be pharmacologically distinguished by their ligand binding signatures. Competition studies were performed to characterize the inhibition of [125I]Ang II binding to each of the cell membrane preparations by an extensive series of peptide and nonpeptide Ang II analogs. Scatchard plot analyses revealed the following binding characteristics: rAT1A - Kd = 1.27 ± 0.14 nM; rAT1B - Site 1: Kd = 0.56±0.11 nM, Site 2: Kd = 126 ± 23 nM;and hAT1 - Site 1: Kd = 1.06 ± 0.16 nM, Site 2: Kd = 257 ± 55 nM. The binding of [125I]Ang II in the three preparations was similarly sensitive to inhibition by GTPγS. The ligand binding signatures of the three receptor isoforms are essentially the same and are illustrated by the affinity and order of potency of the following ligands: L-158,809 ≥ Sar1,Ile8Ang II > saralasin ≥ Ang II ≥ Ang III > EXP581 > EXP3174 > losartan ≥ EXP811 > GR117,289c > EXP6803 > DuP 532 > Ang I ≫ PD123177. In conclusion, the two rat AT1 receptor isoforms are pharmacologically indistinguishable from each other and from that of the human. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:440 / 449
页数:10
相关论文
共 21 条
[1]  
BALLA T, 1991, MOL PHARMACOL, V40, P401
[2]   CLONING AND CHARACTERIZATION OF A HUMAN ANGIOTENSIN-II TYPE-1 RECEPTOR [J].
BERGSMA, DJ ;
ELLIS, C ;
KUMAR, C ;
NUTHULAGANTI, P ;
KERSTEN, H ;
ELSHOURBAGY, N ;
GRIFFIN, E ;
STADEL, JM ;
AIYAR, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (03) :989-995
[3]  
Chiu A T, 1991, Receptor, V1, P133
[4]   CHARACTERIZATION OF ANGIOTENSIN AT1A-RECEPTOR ISOFORM BY ITS LIGAND-BINDING SIGNATURE [J].
CHIU, AT ;
DUNSCOMB, JH ;
MCCALL, DE ;
BENFIELD, P ;
BAUBONIS, W ;
SAUER, B .
REGULATORY PEPTIDES, 1993, 44 (02) :141-147
[5]   INVITRO PHARMACOLOGY OF DUP 753 [J].
CHIU, AT ;
MCCALL, DE ;
PRICE, WA ;
WONG, PC ;
CARINI, DJ ;
DUNCIA, JV ;
WEXLER, RR ;
YOO, SE ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (04) :S282-S287
[6]  
CHIU AT, 1993, CELLULAR MOL BIOL RE, P245
[7]  
CLYNE CD, 1993, FASEB J, V7, pA406
[8]   ISOLATION OF 2 DISTINCT TYPE-I ANGIOTENSIN-II RECEPTOR GENES [J].
ELTON, TS ;
STEPHAN, CC ;
TAYLOR, GR ;
KIMBALL, MG ;
MARTIN, MM ;
DURAND, JN ;
OPARIL, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1067-1073
[9]   MOLECULAR-CLONING AND SEQUENCING OF THE GENE ENCODING HUMAN ANGIOTENSIN-II TYPE-1 RECEPTOR [J].
FURUTA, H ;
GUO, DF ;
INAGAMI, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (01) :8-13
[10]   A SUBFAMILY OF 5-HT1D RECEPTOR GENES [J].
HARTIG, PR ;
BRANCHEK, TA ;
WEINSHANK, RL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (04) :152-159